Key facts
| Price (PPV) | 6,100 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | sofosbuvirvelpatasvir |
| Class | Antivirals for systemic use |
| ATC code | J05AP55 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boite de 28 |
| Nature | Médicament |
| Hospital price | 5,868 MAD |
| Data collected on | 9/8/2026 |
Indications
Epclusa est indiqué pour le traitement de l’infection chronique par le virus de l’hépatite C (VHC) chez les patients âgés de 6 ans et plus et pesant au moins 17 kg
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, one other product contains the same active substance as Epclusa 400 mg / 100 mg (Sofosbuvir | Velpatasvir), at the same strength and in the same dosage form. For the same pack size (Boite de 28), the cheapest is Myhep All 400 mg / 100 mg (VIATRIS PHARMACEUTICALS) at 4,395 MAD, i.e. 28 % less than Epclusa 400 mg / 100 mg (6,100 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Myhep All 400 mg / 100 mg | VIATRIS PHARMACEUTICALS | Boite de 28 | 4,395 MAD | 156.96 / unit | −28 % |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Epclusa 400 mg / 100 mg
Epclusa 400 mg / 100 mg belongs to the antivirals for systemic use therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Epclusa 400 mg / 100 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Epclusa 400 mg / 100 mg
Answers to common questions from Moroccan patients about this drug.